Clinical trial
Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis
NCT01905423 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis
- Lead sponsor
- Washington University School of Medicine
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2011
- Completion date
- December 31, 2015
- Enrollment
- 17,108 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lymphatic filariasis, soil transmitted helminth infections